Covid-19
Brazil turns down request to vaccinate children, adolescents with COVID vaccines
Brazilian Health Regulatory Agency, Anvisa, said it turned down a request by the Brazilian Butantan Institute for approval of Chinese CoronaVac to vaccinate children aged between 3 and 17.
Anvisa stated this on Wednesday that the request was not approved due to lack of sufficient data.
The Instituto Butantan biologic research centre is producing CoronaVac.
“Vaccination of children and teenagers with CoronaVac vaccine is not approved. It was impossible to prove the vaccine’s efficacy and safety for this age group, based on information by the Butantan Institute.
READ ALSO: Actress drops bombshell, advises people not to take COVID vaccines
“Data on immunogenicity leave unclear the duration of protection provided by the immunizing agent,” said Anvisa.
The agency also noted that there was no conclusion on side effects or vaccine efficacy among children with associated diseases, chiefly due to the insufficient number of tests’ participants.
Only the Pfizer/BioNTech vaccine has so far been approved by Anvisa for vaccinating people over 12 years old in Brazil.
However, the Janssen laboratory has received a permit to conduct experiments with children under 18 in the Latin American country
-
Football4 days agoFrance confirms U-20 Women’s World Cup participation amid FIFA-UEFA rift
-
Business4 days agoNigeria’s external debt service falls 31.5% to $954m in Q1 2026
-
Latest4 days agoMessi reportedly faced multiple bomb threats during 2026 World Cup
-
Football2 days agoWAFCON 2026: Super Falcons battle South Africa for World Cup play-off spot
-
Featured4 days agoOsun Governorship Election: Adeleke faces tough test as APC, ADC mount challenge
-
Latest4 days agoNFF denies calling for Infantino’s resignation
-
Latest2 days agoOsun 2026: Oyinlola group backs Oyebamiji, faults Adeleke over exclusion
-
Business4 days agoNNPC faces fresh scrutiny over oil licensing, production claims, transparency